| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |